11 p.-6 fig.Identification of genomic alterations that influence the immune response within the tumor microenvironment is mandatory in order to identify druggable vulnerabilities. In this article, by interrogating public genomic datasets we describe copy number variations (CNV) present in breast cancer (BC) tumors and corresponding subtypes, associated with different immune populations. We identified regulatory T-cells associated with the Basal-like subtype, and type 2 T-helper cells with HER2 positive and the luminal subtype. Using gene set enrichment analysis (GSEA) for the Type 2 T-helper cells, the most relevant processes included the ERBB2 signaling pathway and the Fibroblast Growth Factor Receptor (FGFR) signaling pathway, and for CD8...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
The contribution of germline copy number variants (CNVs) to risk of developing cancer in individuals...
Breast cancer is the most common cancer in women in developed countries, and the contribution of gen...
Copy number alterations (CNAs) are thought to account for 85% of the variation in gene expression ob...
International audienceCancer immunotherapy is revolutionizing the clinical management of several tum...
Introduction: Human epidermal growth factor receptor 2 (HER2)-amplified breast cancer represents a c...
Introduction: HER2 gene amplification and protein overexpression (HER2+) define a clinically challen...
Molecular profiling of thousands of primary breast cancers has uncovered remarkable genomic diversit...
SummaryThis study explores the roles of genome copy number abnormalities (CNAs) in breast cancer pat...
Breast cancers can be divided into subtypes with important implications for prognosis and treatment....
The presence of tumor-infiltrating lymphocytes (TIL) is a favorable prognostic factor in breast canc...
International audienceInflammatory breast cancer (IBC) is the most pro-metastatic form of breast can...
Background: The aim of this paper was to identify an immunotherapy-sensitive subtype for estrogen re...
To better understand the etiology of inflammatory breast cancer (IBC) and identify potential therapi...
Introduction: Familial breast cancer (fBC) is generally associated with an early age of diagnosis an...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
The contribution of germline copy number variants (CNVs) to risk of developing cancer in individuals...
Breast cancer is the most common cancer in women in developed countries, and the contribution of gen...
Copy number alterations (CNAs) are thought to account for 85% of the variation in gene expression ob...
International audienceCancer immunotherapy is revolutionizing the clinical management of several tum...
Introduction: Human epidermal growth factor receptor 2 (HER2)-amplified breast cancer represents a c...
Introduction: HER2 gene amplification and protein overexpression (HER2+) define a clinically challen...
Molecular profiling of thousands of primary breast cancers has uncovered remarkable genomic diversit...
SummaryThis study explores the roles of genome copy number abnormalities (CNAs) in breast cancer pat...
Breast cancers can be divided into subtypes with important implications for prognosis and treatment....
The presence of tumor-infiltrating lymphocytes (TIL) is a favorable prognostic factor in breast canc...
International audienceInflammatory breast cancer (IBC) is the most pro-metastatic form of breast can...
Background: The aim of this paper was to identify an immunotherapy-sensitive subtype for estrogen re...
To better understand the etiology of inflammatory breast cancer (IBC) and identify potential therapi...
Introduction: Familial breast cancer (fBC) is generally associated with an early age of diagnosis an...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
The contribution of germline copy number variants (CNVs) to risk of developing cancer in individuals...
Breast cancer is the most common cancer in women in developed countries, and the contribution of gen...